Form D · Other
Strata Oncology, Inc.
Ann Arbor, MI · CIK 0001668497
Offering snapshot reported Nov 22, 2024 · SEC filing
- Reported sold
- $6.15M Offering amount: $10M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 8, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 22, 2024 | Initial | $6,145,297 | No comparison | 14 | SEC filing |
| Nov 4, 2020 | Initial | $5,000,000 | No comparison | 9 | SEC filing |
| May 11, 2018 | Initial | $11,750,001 | No comparison | 7 | SEC filing |
| Mar 4, 2016 | Initial | $6,303,544 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530232
Source: Form D, filed Nov 22, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Burkoth | Director |
| Keith Flaherty | Director |
| Jan Garfinkle | Director |
| Matthew Martin | Executive |
| Christopher O'donnell | Director |
| James Pavlik | Director |
| Daniel Rhodes | Director, Executive |
| David Rubin | Director |
| Prem Tumkosit | Director |
| Nicole Walker | Director |
| Jeffrey Williams | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
8170 Jackson Rd. Suite A
Ann Arbor, MI, 48103
Ann Arbor, MI, 48103